Ftse Mib
37.977,59
0,18%
DAX
22.513,42
-0,43%
S&P 500
6.114,63
-0,01%
NASDAQ
20.026,77
0,41%
Bitcoin
97.598,82
0,08%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Nevro Corp (NVRO) Nevro Corp (NVRO) Notizie

Nevro Corp

NVRO
5,71
-0,01 (-0,17%)
14 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/2/202523:14EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
14/2/202519:09EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
10/2/202515:11PRNUSKuehn Law Encourages NVRO, SLRN, TGI, and PTMN Investors to..
06/2/202522:07EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06/2/202522:05EDGAR2Form 8-K - Current report
06/2/202515:30GLOBEGlobus Medical to Acquire Nevro Corp. to Expand Treatment..
27/1/202522:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/1/202522:30PRNUSNevro Announces New Employee Inducement Grants Under NYSE..
14/1/202518:29EDGAR2Form 8-K - Current report
13/1/202514:30PRNUSNevro Announces Preliminary Fourth-Quarter and Full-Year..
06/1/202522:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202522:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/12/202422:30PRNUSNevro Announces New Employee Inducement Grants Under NYSE..
09/12/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/12/202422:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/12/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202422:27EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
02/12/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202414:30PRNUSNew Study Demonstrates Multiple Advantages of Nevro1™, the..
15/11/202414:30PRNUSNevro Announces New Employee Inducement Grants Under NYSE..
14/11/202423:31EDGAR2Form SC 13D/A - General Statement of Acquisition of..
14/11/202423:18EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202422:11EDGAR2Form 8-K - Current report
12/11/202413:00PRNUSNevro's HFX iQ™ Spinal Cord Stimulation with AI Technology..
11/11/202422:05PRNUSNevro Reports Third-Quarter 2024 Financial Results
08/11/202420:17EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
29/10/202421:30PRNUSNew Data Demonstrates Long-Term Improvements in Pain..
28/10/202421:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/10/202422:30PRNUSNevro Announces New Employee Inducement Grants Under NYSE..
10/10/202422:45PRNUSNevro to Report Third-Quarter 2024 Financial Results and..
08/10/202423:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202422:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/9/202414:00PRNUSNevro Announces the Launch of HFX AdaptivAI™, the Only..
23/9/202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/9/202422:30PRNUSNevro Announces New Employee Inducement Grants Under NYSE..
10/9/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/9/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/9/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202422:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202422:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202422:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/8/202422:15PRNUSNevro to Present at Wells Fargo 2024 Healthcare Conference
14/8/202422:30PRNUSNevro Announces New Employee Inducement Grants Under NYSE..
06/8/202422:48EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/8/202422:15EDGAR2Form 8-K - Current report
06/8/202422:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/8/202422:05PRNUSNevro Reports Second-Quarter 2024 Financial Results
Apertura: 5,73 Min: 5,71 Max: 5,73
Chiusura: 5,72

La tua Cronologia

NYSE
NVRO
Nevro
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci